115 related articles for article (PubMed ID: 8303732)
1. Hemostatic markers in acute transient ischemic attacks.
Fon EA; Mackey A; Côté R; Wolfson C; McIlraith DM; Leclerc J; Bourque F
Stroke; 1994 Feb; 25(2):282-6. PubMed ID: 8303732
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic markers in ischemic stroke of undetermined etiology.
Ince B; Bayram C; Harmanci H; Ulutin T
Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic markers in patients at risk of cerebral ischemia.
Côté R; Wolfson C; Solymoss S; Mackey A; Leclerc JR; Simard D; Rouah F; Bourque F; Léger B
Stroke; 2000 Aug; 31(8):1856-62. PubMed ID: 10926947
[TBL] [Abstract][Full Text] [Related]
4. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic molecular markers in nephrotic syndrome.
Chen TY; Huang CC; Tsao CJ
Am J Hematol; 1993 Dec; 44(4):276-9. PubMed ID: 8238000
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans.
Ceriello A; Giugliano D; Quatraro A; Marchi E; Barbanti M; Lefèbvre P
Diabetologia; 1990 Mar; 33(3):163-7. PubMed ID: 2184068
[TBL] [Abstract][Full Text] [Related]
8. Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.
Haaland AK; Skjønsberg OH; Gravem K; Ruyter R; Godal HC
Thromb Res; 1991 Feb; 61(3):253-9. PubMed ID: 2028444
[TBL] [Abstract][Full Text] [Related]
9. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
[TBL] [Abstract][Full Text] [Related]
12. Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks.
Vicari AM; Giusti MC; Luoni R; Macagni A; Medaglini S; Seveso MP; Franceschi M
Stroke; 1987; 18(5):892-5. PubMed ID: 2957821
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients.
Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
Stroke; 1991 Nov; 22(11):1369-73. PubMed ID: 1836283
[TBL] [Abstract][Full Text] [Related]
15. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
[TBL] [Abstract][Full Text] [Related]
16. The coagulation system is activated in idiopathic cardiomyopathy.
Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Mombelli G; Marchetti O; Haeberli A; Straub PW
Am Heart J; 1998 Dec; 136(6):1106-13. PubMed ID: 9842027
[TBL] [Abstract][Full Text] [Related]
18. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
Koyama T; Aoki N
Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
[TBL] [Abstract][Full Text] [Related]
19. Procoagulant and proinflammatory activity in acute coronary syndromes.
Manten A; de Winter RJ; Minnema MC; ten Cate H; Lijmer JG; Adams R; Peters RJ; van Deventer SJ
Cardiovasc Res; 1998 Nov; 40(2):389-95. PubMed ID: 9893733
[TBL] [Abstract][Full Text] [Related]
20. Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Sturzenegger M; Beer JH; Rihs F
Stroke; 1995 Jan; 26(1):63-9. PubMed ID: 7839399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
